June 7, 2019 11:00 AM EDTUpdated July 3, 10:27 AM

Hansoh grabs $1B windfall in the latest China pharma IPO to hit the Hong Kong exchange

John Carroll

Editor & Founder

China’s fast-growing pharma powerhouse Hansoh Pharmaceutical has raised a billion dollars in the latest IPO to hit the Hong Kong exchange. And the green shoe …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Hansoh grabs $1B windfall in the latest China pharma IPO to hit the Hong Kong exchange

John Carroll

Editor & Founder

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Sanofi to pay $125M upfront for two immunology drugs from little-known biotech

US drugs rely heavily on ingredients made overseas, new report shows

Exclusive: VelaVigo inks another US biotech deal as China drug development scene booms

Biotech seed rounds sink to lowest level in years as industry slump drags on

Sarepta loses CMO to RNA editing upstart; Another wave of personnel moves at Dyne

New York-based partnership sets the standard for expanding clinical trial access for underserved and diverse ...

Han­soh grabs $1B wind­fall in the lat­est Chi­na phar­ma IPO to hit the Hong Kong ex­change

Editor & Founder

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Hansoh grabs $1B windfall in the latest China pharma IPO to hit the Hong Kong exchange